Client News

Newron to present at the 34th CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)

Medigene AG: Medigene acquires worldwide, exclusive license of CD40L-CD28 Costimulatory Switch Receptor

Abivax: Publication of an expert article in JCC on obefazimod as promising therapeutic management option for UC patients

Newron announces Senior Management Team changes

Destiny Pharma and SporeGen® announce update from research collaboration under Innovate UK grant award to develop a biotherapeutic treatment (SPOR-COV®) for COVID-19 and Influenza

Mainz Biomed to Participate in Digestive Disease Week 2023

Rentschler Biopharma Receives Worcester Business Journal 2023 Manufacturing Excellence Award

LEON sets up lab facilities at the Innovation and Start-Up Center for Biotechnology (IZB) in Munich

Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany

Mainz Biomed announces partnership with the Instituto de Microecologia to Expand ColoAlert® commercialization in Spain and Portugal